Issue areas declared on the filings, ranked by how many filings name each one.
Pharmacy
PHA · 1 client
48 filings
$9.5M on those filings
Manufacturing
MAN · 1 client
18 filings
$5.6M on those filings
Health Issues
HCR · 1 client
Who does the lobbying
Every lobbyist named on this registrant's filings.
Steven GiuliCovered position: Legislative Director, Congressman Frank Pallone75 filings1 client · through 2026
Covered positions · 1 of 1 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
Foreign interests disclosed
Every foreign entity named on this registrant's filings.
Apotex Inc.
Canada
3 filings
through 2025
Apotex Holdco Inc. (Ontario REGISTERED)(HOLDCO)
Canada
1 filing
through 2024
The filings
The 20 most recent of 69 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: apotex-corp.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Reading this · An LD-2 reports either a fee the registrant charged or expenses it spent, never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. The expenses basis is what an organization lobbying on its own behalf files — usually for itself, sometimes for an affiliate under a different name — so a name on the second list is the client the filing names, not necessarily a claim that the registrant lobbied for someone else's account. Across every relationship on file — not just those shown — this registrant reported $0 in fees and $15.9M in expenses.
18 filings
$5.4M on those filings
Copyright/Patent/Trademark
CPT · 1 client
14 filings
$4.1M on those filings
Trade (domestic/foreign)
TRD · 1 client
12 filings
$4.1M on those filings
Medicare/Medicaid
MMM · 1 client
10 filings
$1.9M on those filings
Tariff (miscellaneous tariff bills)
TAR · 1 client
4 filings
$1.7M on those filings
Budget/Appropriations
BUD · 1 client
2 filings
$650K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore money on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Artemis Intermediate Holdings, Inc. (Ontario REGISTERED)(AIHI)
Canada
1 filing
through 2024
Artemis Parent, Inc.
Canada
1 filing
through 2024
Apotex Pharmaceutical Holdings Inc. (Apshi)
Canada
1 filing
through 2023
Artemis Intermediate Holdings Inc.
Canada
1 filing
through 2023
Artemis Parent Inc.
Canada
1 filing
through 2023
What this discloses · An LD-2 reports foreign entities that hold an interest in, or contribute to, the client — so these are foreign interests behind the organizations this registrant files for, not owners of the registrant itself. Disclosure is a reporting requirement, not an allegation.
